Translational Medicine

An increasingly important biomedical speciality

Webinars, events, articles and multi-media lectures


In a series of webinars, events and in other media we shall be exploring how the practice of Translational Medicine is evolving to play an increasingly important role in improving healthcare and targeting the unmet needs of patients.

We shall be covering operational strategies and career structures in a discipline at the frontier where complex management meets multi-disciplinary science.

In the upcoming webinar on Immunogenicity for Biotherapeutics in Drug Development to be held on June 29, 2022 we continue the series highlighting solutions to challenges in Translational Medicine.

Join us as we seek to clarify some of the myths around immunogenicity, factors that contribute to the identification, classification, and prediction of immunogenicity risks, and how to measure immune responses to biotherapeutics. An important goal is to understand the impact of immunogenicity on the clinical efficacy and safety of drugs - including how to mitigate and manage such impacts during the process of developing biotherapeutics. 

A panel of Translational Medicine experts from big pharma, biotech and academia will discuss:

  • What is the general understanding of the concepts that underlie immunogenicity? 
  • Why are robust, sensitive, and specific anti-drug-antibody (ADA) assays essential?
  • Why is early risk assessment and mitigation key?
  • How should we evaluate and interpret immunogenicity data from pre-clinical and clinical studies?
  • What are the clinical risk mitigation and management strategies that can be employed?

Register here >


Webinars, events, articles and multi-media lectures